Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/03/2026 ,inter alia, to consider and approve Independent Directors Meeting

Shukra Pharmaceuticals has informed BSE that a separate meeting of its Independent Directors will be held on Monday, 16 March 2026 at the company's registered office in Ahmedabad. The meeting's agenda includes reviewing the performance of Non-Independent Directors and the Board as a whole, evaluating the Chairman's performance, and assessing the quantity, quality and timeliness of information flow to the Board. Any other business may be taken up with the Chair's permission. This is a routine corporate governance exercise mandated under SEBI's Listing Regulations for listed companies and does not involve any financial decisions, dividend, fundraising, or strategic action.